139 related articles for article (PubMed ID: 7710303)
1. Different effects of the histamine H2 receptor blockers, famotidine and zolantidine, on the human atrium in vitro.
Poli E; Pozzoli C; Barboso G; Bertaccini G
Arch Int Pharmacodyn Ther; 1994; 328(2):180-90. PubMed ID: 7710303
[TBL] [Abstract][Full Text] [Related]
2. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
3. Effects of histamine H2 receptor agonists and antagonists on the isolated guinea pig gallbladder.
Coruzzi G; Pozzoli C; Poli E; Coppelli G; Bertaccini G
Fundam Clin Pharmacol; 1999; 13(1):84-90. PubMed ID: 10027092
[TBL] [Abstract][Full Text] [Related]
4. Chronic beta 1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: rôle of cyclic nucleotides.
Sanders L; Lynham JA; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):661-70. PubMed ID: 8738299
[TBL] [Abstract][Full Text] [Related]
5. A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.
Takahama H; Asanuma H; Sanada S; Fujita M; Sasaki H; Wakeno M; Kim J; Asakura M; Takashima S; Minamino T; Komamura K; Sugimachi M; Kitakaze M
Basic Res Cardiol; 2010 Nov; 105(6):787-94. PubMed ID: 20852875
[TBL] [Abstract][Full Text] [Related]
6. [Action of famotidine, a new H2-receptor antagonist, on the papillary muscle and atrium of the guinea pig, in vitro].
Poli E; Coruzzi G; Bertaccini G
Cardiologia; 1987 Sep; 32(9):1025-9. PubMed ID: 2891444
[No Abstract] [Full Text] [Related]
7. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
8. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.
Calcutt CR; Ganellin CR; Griffiths R; Leigh BK; Maguire JP; Mitchell RC; Mylek ME; Parsons ME; Smith IR; Young RC
Br J Pharmacol; 1988 Jan; 93(1):69-78. PubMed ID: 2894879
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
Gogas KR; Hough LB
J Pharmacol Exp Ther; 1989 Jan; 248(1):262-7. PubMed ID: 2563290
[TBL] [Abstract][Full Text] [Related]
10. Sleep variables are unaltered by zolantidine in rats: are histamine H2-receptors not involved in sleep regulation?
Monti JM; Orellana C; Boussard M; Jantos H; Olivera S
Brain Res Bull; 1990 Aug; 25(2):229-31. PubMed ID: 1977498
[TBL] [Abstract][Full Text] [Related]
11. Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia.
Gogas KR; Hough LB
Neuropharmacology; 1988 Apr; 27(4):357-62. PubMed ID: 2901671
[TBL] [Abstract][Full Text] [Related]
12. [Negative inotropic action of famotidine].
Kirch W; Halabi A; Linde M; Ohnhaus EE
Schweiz Med Wochenschr; 1988 Dec; 118(50):1912-4. PubMed ID: 2906174
[TBL] [Abstract][Full Text] [Related]
13. Does histamine stimulate cyclic AMP formation in the avian pineal gland via a novel (non-H1, non-H2, non-H3) histamine receptor subtype.
Nowak JZ; Sek B; D'Souza T; Dryer SE
Neurochem Int; 1995 Dec; 27(6):519-26. PubMed ID: 8574181
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H1, H2 and H3 receptor agonists and antagonists.
Gespach C; Fagot D; Emami S
Eur J Clin Invest; 1989 Feb; 19(1):1-10. PubMed ID: 2567239
[TBL] [Abstract][Full Text] [Related]
15. The cardiac pharmacology of tiotidine (LCL 125, 211): a new histamine H2-receptor antagonist.
Trzeciakowski JP; Levi R
J Pharmacol Exp Ther; 1980 Sep; 214(3):629-34. PubMed ID: 6105207
[TBL] [Abstract][Full Text] [Related]
16. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
17. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
Hough LB; Nalwalk JW
Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
[TBL] [Abstract][Full Text] [Related]
19. Inotropic effects of histamine in human myocardium: differentiation between positive and negative components.
Guo ZG; Levi R; Graver LM; Robertson DA; Gay WA
J Cardiovasc Pharmacol; 1984; 6(6):1210-5. PubMed ID: 6084781
[TBL] [Abstract][Full Text] [Related]
20. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice.
Suzuki T; Takamori K; Misawa M; Onodera K
Brain Res; 1995 Mar; 675(1-2):195-202. PubMed ID: 7796129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
